Abstract
The development of hepatocellular carcinoma is insidious and rapid. Most patients can not undergo surgery after diagnosis. Transcatheter arterial chemoembolization (TACE) is considered to be the best modality for treatment of advanced hepatocellular carcinoma. However, there are some bottlenecks in TACE, such as low targeting of chemotherapy drugs and incomplete treatment. How to improve the curative effect of TACE has become a key issue in the interventional treatment of hepatocellular carcinoma. In recent years, the study of nano-drug delivery systems has been expected to solve these problems, and has become a hot spot in the field of targeted therapy for hepatocellular carcinoma. In this paper, the current research status of nano-drug delivery systems and its application in the interventional-targeted therapy of hepatocellular carcinoma are reviewed. Key words: Nano-drug; Radiology, interventional; Carcinoma, hepatocellular
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
